Participation of Two Ser-Ser-Phe-Tyr Repeats in Interleukin-6 (IL-6)-Binding Sites of the Human IL-6 Receptor
Open Access
- 15 June 1996
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 238 (3), 714-723
- https://doi.org/10.1111/j.1432-1033.1996.0714w.x
Abstract
The α-subunit of interleukin-6 (IL-6) receptor is a member of the hematopoietin receptor family. The alignment of its amino acid sequence with those of other members of this family (human somatotropin receptor/murine IL-3 receptor β and human IL-2 receptor β) has suggested that amino acids included in two SSFY repeats found in each of its hematopoietin receptor domains, contribute to the binding of the ligand. The involvement of these amino acids in IL-6 binding and signal transduction was studied by site-directed mutagenesis and molecular modelling. We present a computer-derived three-dimensional model of the IL-6/IL-6 receptor complex based on the structure of the human somatotropin/human somatotropin receptor complex. This model allowed the location of distinct regions important for IL-6 and gp130 binding. We show that some of the residues included in the SSFY repeats located in our IL-6 receptor model in the loops between β-strands E and F of domain-I and B' and C', of domain-II, participate in the formation of a major IL-6-binding site. These residues are necessary for IL-6 and gp130 binding and for signal transduction. Using our IL-6 receptor mutants we mapped the epitopes of four anti-(IL-6 receptor) neutralising monoclonal antibodies to these residues. Our results demonstrate that a generic hematopoietin receptor family structural module can be used for the study of both α and β receptor subunits belonging to this family.Keywords
This publication has 36 references indexed in Scilit:
- Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells.The Journal of Experimental Medicine, 1994
- Mutagenesis of the human interleukin‐6 fourth predicted α‐helix: Involvement of the Arg168 in the binding siteEuropean Journal of Immunology, 1994
- IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine KinaseScience, 1993
- Anti‐human interleukin‐6 receptor antibody inhibits human myeloma growth in vivoEuropean Journal of Immunology, 1992
- MOLSCRIPT: a program to produce both detailed and schematic plots of protein structuresJournal of Applied Crystallography, 1991
- Molecular cloning and expression of an IL-6 signal transducer, gp130Cell, 1990
- High- and low-affinity receptors for murine interleukin 6. distinct distribution on b and t cellsEuropean Journal of Immunology, 1989
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989
- Cloning and Expression of the Human Interleukin-6 (BSF-2/IFNβ 2) ReceptorScience, 1988
- High‐affinity binding sites for human 26‐kDa protein (interleukin 6, B cell stimulatory factor‐2, human hybridoma plasmacytoma growth factor, interferon‐β2), different from those of type I interferon (α,β), on lymphoblastoid cellsEuropean Journal of Immunology, 1987